Kui Wang
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Hepatology 27
- Hepatocellular Carcinoma Treatment and Prognosis 26
- Surgery 22
- Cholangiocarcinoma and Gallbladder Cancer Studies 19
- Co-authors
- Yong Xia (33 shared papers)Feng Shen (31 shared papers)Mengchao Wu (18 shared papers)Xuying Wan (16 shared papers)Dong Wu (14 shared papers)Zhenlin Yan (20 shared papers)Jun Li (14 shared papers)Wan Yee Lau (18 shared papers)
- Journals
- Oncotarget (4 papers)Journal of Clinical Oncology (4 papers)Surgery (3 papers)The Oncologist (3 papers)Annals of Surgical Oncology (3 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Kui Wang
68 papers receiving 2.9k citations
Kui Wang's Hit Papers
Peers
Comparison fields: 5 of 112
- Hepatology 1.0k
- Cancer Research 342
- Surgery 875
- Oncology 393
- Pulmonary and Respiratory Medicine 385
Countries citing papers authored by Kui Wang
This map shows the geographic impact of Kui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kui Wang more than expected).
Fields of papers citing papers by Kui Wang
This network shows the impact of papers produced by Kui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kui Wang. The network helps show where Kui Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Kui Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy Hit paper breakdown → | 2013 | 849 |
| 2 | Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus–Related Hepatocellular Carcinoma Within the Milan Criteria Hit paper breakdown → | 2015 | 466 |
| 3 | 2021 | 179 | |
| 4 | 2014 | 135 | |
| 5 | 2019 | 132 | |
| 6 | 2007 | 103 | |
| 7 | 2018 | 83 | |
| 8 | 2018 | 73 | |
| 9 | 2010 | 65 | |
| 10 | 2020 | 56 | |
| 11 | 2017 | 52 | |
| 12 | 2015 | 50 | |
| 13 | 2016 | 44 | |
| 14 | 2016 | 42 | |
| 15 | 2015 | 38 | |
| 16 | 2016 | 38 | |
| 17 | 2016 | 38 | |
| 18 | 2010 | 37 | |
| 19 | 2012 | 34 | |
| 20 | 2017 | 31 |
About Kui Wang
Kui Wang is a scholar working on Hepatology, Surgery, Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, having authored 75 papers that have together received 3.0k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (26 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers), Liver Disease Diagnosis and Treatment (4 papers), Cancer, Lipids, and Metabolism (4 papers), Gallbladder and Bile Duct Disorders (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Hepatology (1.0k citations), Cancer Research (342 citations), Surgery (875 citations), Oncology (393 citations) and Pulmonary and Respiratory Medicine (385 citations). Kui Wang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yong Xia, Feng Shen, Mengchao Wu, Xuying Wan, Dong Wu, Zhenlin Yan, Jun Li, Wan Yee Lau, Lehua Shi and Anfeng Si. Their work appears in journals such as Oncotarget, Journal of Clinical Oncology, Surgery, The Oncologist and Annals of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.